Literature DB >> 17176072

P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites.

Poulomi Acharya1, Thuy T Tran, Joseph W Polli, Andrew Ayrton, Harma Ellens, Joe Bentz.   

Abstract

The multidrug resistance transporter P-glycoprotein (P-gp) effluxes a wide range of substrates and can be affected by a wide range of inhibitors or modulators. Many studies have presented classifications for these binding interactions, within either the context of equilibrium binding or the Michaelis-Menten enzyme analysis of the ATPase activity of P-gp. Our approach is to study P-gp transport and its inhibition using a physiologically relevant confluent monolayer of hMDR1-MDCKII cells. We measure the elementary rate constants for P-gp efflux of substrates and study inhibition using pairwise combinations with a different unlabeled substrate acting as the inhibitor. Our current kinetic model for P-gp has only a single binding site, because a previous study proved that the mass-action kinetics of efflux of a single substrate were not sensitive to whether there are one or more substrate-binding and efflux sites. In this study, using this one-site model, we found that, with "high" concentrations of either a substrate or an inhibitor, the elementary rate constants fitted independently for each of the substrates alone quantitatively predicted the efflux curves, simply applying the assumption that binding at the "one site" was competitive. On the other hand, at "low" concentrations of both the substrate and inhibitor, we found no inhibition of the substrate efflux, despite the fact that both the substrate and inhibitor were being well-effluxed. This was not an effect of excess "empty" P-gp molecules, because the competitive efflux model takes site occupancy into account. Rather, it is quantitative evidence that the substrate and inhibitor are being effluxed by multiple pathways within P-gp. Remarkably, increasing the substrate concentration above the "low" concentration, caused the inhibition to become competitive; i.e., the inhibitor became effective. These data and their analysis show that the binding of these substrates must be cooperative, either positive or negative.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17176072     DOI: 10.1021/bi060593b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells.

Authors:  Yun-Xia Li; Liang-Hong Ye; Xue-Hua Jiang; Cheng Peng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-02-20       Impact factor: 2.441

2.  Substrate-dependent breast cancer resistance protein (Bcrp1/Abcg2)-mediated interactions: consideration of multiple binding sites in in vitro assay design.

Authors:  Nagdeep Giri; Sagar Agarwal; Naveed Shaik; Guoyu Pan; Ying Chen; William F Elmquist
Journal:  Drug Metab Dispos       Date:  2008-12-04       Impact factor: 3.922

3.  Case Study 8: Status of the Structural Mass Action Kinetic Model of P-gp-Mediated Transport Through Confluent Cell Monolayers.

Authors:  Joe Bentz; Harma Ellens
Journal:  Methods Mol Biol       Date:  2021

4.  A novel screening strategy to identify ABCB1 substrates and inhibitors.

Authors:  Oliver von Richter; Hristos Glavinas; Peter Krajcsi; Stephanie Liehner; Beate Siewert; Karl Zech
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-08-29       Impact factor: 3.000

5.  Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells.

Authors:  Sandrine Lemaire; Françoise Van Bambeke; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2007-06-04       Impact factor: 5.191

6.  Fitting the elementary rate constants of the P-gp transporter network in the hMDR1-MDCK confluent cell monolayer using a particle swarm algorithm.

Authors:  Deep Agnani; Poulomi Acharya; Esteban Martinez; Thuy Thanh Tran; Feby Abraham; Frank Tobin; Harma Ellens; Joe Bentz
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

7.  Involvement of human and canine MRP1 and MRP4 in benzylpenicillin transport.

Authors:  Xiaofen Zhao; Yangfang Li; Kun Du; Yuqin Wu; Ling Liu; Shan Cui; Yan Zhang; Jin Gao; Richard F Keep; Jianming Xiang
Journal:  PLoS One       Date:  2019-11-27       Impact factor: 3.240

8.  Actin polymerization controls the activation of multidrug efflux at fertilization by translocation and fine-scale positioning of ABCB1 on microvilli.

Authors:  Kristen Whalen; Adam M Reitzel; Amro Hamdoun
Journal:  Mol Biol Cell       Date:  2012-08-01       Impact factor: 4.138

9.  Transport inhibition of digoxin using several common P-gp expressing cell lines is not necessarily reporting only on inhibitor binding to P-gp.

Authors:  Annie Albin Lumen; Libin Li; Jiben Li; Zeba Ahmed; Zhou Meng; Albert Owen; Harma Ellens; Ismael J Hidalgo; Joe Bentz
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

10.  State-dependent inhibition of BK channels by the opioid agonist loperamide.

Authors:  Alexandre G Vouga; Michael E Rockman; Jiusheng Yan; Marlene A Jacobson; Brad S Rothberg
Journal:  J Gen Physiol       Date:  2021-08-06       Impact factor: 4.086

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.